Author details

Full Name

Chih-Cheng Yang

Affiliation

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
33440148	MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.	Cell Rep	2021
34462276	Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.	Cancer Res	2021
32839770	SARS-CoV-2 ORF9c Is a Membrane-Associated Protein that Suppresses Antiviral Responses in Cells.	bioRxiv	2020
31627132	Cross Talk between eIF2Î± and eEF2 Phosphorylation Pathways Optimizes Translational Arrest in Response to Oxidative Stress.	iScience	2019
27453043	A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.	Mol Cell	2016
28773815	Improvement of the Mechanical Properties of 1022 Carbon Steel Coil by Using the Taguchi Method to Optimize Spheroidized Annealing Conditions.	Materials (Basel)	2016
26091350	Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass.	Oncotarget	2015
26118643	Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates.	Mol Cell	2015
24391461	An MBS-assisted femtocell transmit power control scheme with mobile user QoS guarantee in 2-tier heterogeneous femtocell networks.	ScientificWorldJournal	2013
21747542	Three-dimensional illumination system using dielectric liquid lenses.	Opt Express	2011
21182779	Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells.	BMC Biol	2010
21267438	Miniaturization of dielectric liquid microlens in package.	Biomicrofluidics	2010
19411063	Inflamed snail speeds metastasis.	Cancer Cell	2009
17960496	Ca2+ binding protein-1 inhibits Ca2+ currents and exocytosis in bovine chromaffin cells.	J Biomed Sci	2008
18598074	Exocytosis of a single bovine adrenal chromaffin cell: the electrical and morphological studies.	J Phys Chem B	2008
18413750	Targeting endoplasmic reticulum stress and Akt with OSU-03012 and gefitinib or erlotinib to overcome resistance to epidermal growth factor receptor inhibitors.	Cancer Res	2008
17409431	Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.	Cancer Res	2007
17569795	Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.	Mol Pharmacol	2007
17545612	Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.	Cancer Res	2007
16520381	alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function.	J Biol Chem	2006
16452400	Peroxisome proliferator-activated receptor gamma-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells.	Mol Pharmacol	2006
15735046	Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.	Cancer Res	2005
15634661	Growth inhibitory effects of celecoxib in human umbilical vein endothelial cells are mediated through G1 arrest via multiple signaling mechanisms.	Mol Cancer Ther	2004
12738789	Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.	J Biol Chem	2003
11555646	Specific binding of the C-terminal Src homology 2 domain of the p85alpha subunit of phosphoinositide 3-kinase to phosphatidylinositol 3,4,5-trisphosphate. Localization and engineering of the phosphoinositide-binding motif.	J Biol Chem	2001

1 - 25 of 25

Anjali V Sheahan

Dana-Farber Cancer Institute

Career Start Year 2012

Number of shared co-authors 2

Shuai Gao

Center for Personalized Cancer Therapy, University of Massachusetts Boston

Career Start Year 2012

Number of shared co-authors 0

Rahul Kumar

Roswell Park Comprehensive Cancer Center

Career Start Year 2009

Number of shared co-authors 0

Yu Chen

School of Pharmacy, University of Wisconsin-Madison

Career Start Year 2008

Number of shared co-authors 1

Young K Song

National Cancer Institute, National Institutes of Health

Career Start Year 2007

Number of shared co-authors 0

Hui Xue

Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences

Career Start Year 2005

Number of shared co-authors 2

Guan Wang

Jilin University

Career Start Year 2005

Number of shared co-authors 0

Xiaohu Zhang

National Center for Advancing Translational Sciences

Career Start Year 2003

Number of shared co-authors 0

Yan Zeng

Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College

Career Start Year 2003

Number of shared co-authors 3

Yong Jae Shin

Cancer Stem Cell Research Center, Samsung Biomedical Research Institute

Career Start Year 2001

Number of shared co-authors 0

Amina Zoubeidi

University of British Columbia

Career Start Year 2000

Number of shared co-authors 2

Fan Yang

West China Second Hospital, Sichuan University

Career Start Year 2000

Number of shared co-authors 0

Vivek Shukla

Chalmers University of Technology

Career Start Year 2000

Number of shared co-authors 1

Yuzhuo Wang

University of British Columbia

Career Start Year 2000

Number of shared co-authors 2

Ming Zhan

Ningbo First Hospital, Zhejiang University

Career Start Year 2000

Number of shared co-authors 0

Yan Liu

Chengdu Medical College

Career Start Year 1999

Number of shared co-authors 0

Kristiina Iljin

VTT Technical Research Centre of Finland Ltd

Career Start Year 1999

Number of shared co-authors 0

Erxi Wu

Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin

Career Start Year 1997

Number of shared co-authors 1

Dongquan Chen

University of Alabama at Birmingham

Career Start Year 1997

Number of shared co-authors 0

Chun-Liang Chen

National Dong Hwa University

Career Start Year 1997

Number of shared co-authors 0

Jong Bae Park

Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University

Career Start Year 1997

Number of shared co-authors 0

Matthew B Rettig

David Geffen School of Medicine, University of California los angeles

Career Start Year 1995

Number of shared co-authors 2

Ning Guo

Beijing Tongren Hospital, Capital Medical University

Career Start Year 1995

Number of shared co-authors 0

Mingyao Liu

The Institute of Biomedical Sciences, East China Normal University

Career Start Year 1994

Number of shared co-authors 0

Christopher M Hovens

Royal Melbourne Hospital, The University of Melbourne

Career Start Year 1989

Number of shared co-authors 1

Sun Young Kim

Asan Medical Center, University of Ulsan College of Medicine

Career Start Year 1988

Number of shared co-authors 0

Rakesh Kumar

Rutgers New Jersey Medical School

Career Start Year 1987

Number of shared co-authors 3

Massimo Loda

Weill Medical College of Cornell University

Career Start Year 1984

Number of shared co-authors 2

John A Copland

Mayo Clinic Jacksonville

Career Start Year 1982

Number of shared co-authors 0

Francisca Vazquez

Broad Institute of MIT and Harvard

Career Start Year 1979

Number of shared co-authors 2

row(s) 1 - 30 of 30

Pedro Aza-Blanc

Sanford-Burnham-Prebys Medical Discovery Institute

Co-authored papers 3

Ze'ev Ronai

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 2

Laura Martin-Sancho

The Scripps Research Institute

Co-authored papers 1

Ana Bojorquez-Gomez

University of California

Co-authored papers 1

Matthew D Ringel

The Ohio State University College of Medicine and Comprehensive Cancer Center

Co-authored papers 1

Leonie Kollenstart

Leiden University Medical Center

Co-authored papers 1

Rabi Murad

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

James Jensen

University of California San Diego

Co-authored papers 1

Jun Yin

Co-authored papers 1

Daniel Pekin

University of California

Co-authored papers 1

David E Gordon

Emory University

Co-authored papers 1

Andrew M Gross

Illumina Inc.

Co-authored papers 1

Nevan J Krogan (CM4AI)

University of California San Francisco

Co-authored papers 1

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Co-authored papers 1

Hyungsoo Kim

Sungkyunkwan University

Co-authored papers 1

Xin Yin

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

Haico van Attikum

Leiden University Medical Center

Co-authored papers 1

Ana Dominguez Andres

Co-authored papers 1

Sunnie M Yoh

Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

Judd F Hultquist

Northwestern University Feinberg School of Medicine

Co-authored papers 1

Andrew V Kossenkov

The Wistar Institute

Co-authored papers 1

Rohith Srivas

Amgen Inc.

Co-authored papers 1

Brian James

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

Yongmei Feng

Cancer Center, Sanford Burnham Prebys Medical Discovery Institute

Co-authored papers 1

Martin E Gleave

University of British Columbia

Co-authored papers 1

Jia L Xu

Stem Cell Program and Institute for Genomic Medicine, University of California

Co-authored papers 1

Ladan Fazli

University of British Columbia

Co-authored papers 1

Katherine Licon

University of California San Diego

Co-authored papers 1

Meenhard Herlyn

Ellen and Ronald Caplan Cancer Center, The Wistar Institute

Co-authored papers 1

Robert W Sobol

University of South Alabama

Co-authored papers 1

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators